目次

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations

3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation

4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities

5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis

6. GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE
6.1. Overview
6.2. DNA Isolation & Purification
6.3. RNA Isolation & Purification

7. GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD
7.1. Overview
7.2. Column-Based
7.3. Magnetic Beads
7.4. Reagent-Based
7.5. Others

8. GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION
8.1. Overview
8.2. Precision Medicine
8.3. Diagnostics
8.4. Drug Discovery & Development
8.5. Agriculture and Animal Research
8.6. Others

9. GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION
9.1. Overview
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. France
9.2.3. UK
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. Australia
9.3.6. Rest of Asia-Pacific
9.4. Rest of the World
9.4.1. Middle East
9.4.2. Africa
9.4.3. Latin America

10. COMPETITIVE LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Nucleic Acid Isolation And Purification Market,
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global Nucleic Acid Isolation And Purification Market,
10.7. Key developments and Growth Strategies
10.7.1. New Product Launch/Service Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income, 2023
10.8.2. Major Players R&D Expenditure. 2023

11. COMPANY PROFILES
11.1. QIAGEN
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Products Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Thermo Fisher Scientific, Inc.
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Products Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. Illumina, Inc.
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Products Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Danaher Corporation
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Products Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. F. Hoffmann-La Roche Ltd
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Products Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. Merck KGaA
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Products Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Agilent Technologies
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Products Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. BIO-RAD LABORATORIES, INC.
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Products Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Takara Bio Inc.
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Products Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. Promega Corporation
11.10.1. Company Overview
11.10.2. Financial Overview
11.10.3. Products Offered
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies

12. APPENDIX
12.1. References
12.2. Related Reports

LIST OF TABLES
TABLE 1 GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 5 GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 7 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 9 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 10 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 11 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 12 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 13 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 14 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 1 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 2 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 3 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 4 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 5 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 6 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 7 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 8 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 9 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 10 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 11 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 12 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 13 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 14 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 15 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 16 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 17 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 18 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 19 ASIA-PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 20 ASIA-PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 21 ASIA-PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 22 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 23 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 24 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 25 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 26 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 27 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 28 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 29 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 30 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 31 AUSTRALIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 32 AUSTRALIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 33 AUSTRALIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 34 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 35 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 36 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 37 REST OF ASIA-PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 38 REST OF ASIA-PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 39 REST OF ASIA-PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 40 REST OF THE WORLD: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 41 REST OF THE WORLD: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 42 REST OF THE WORLD: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 43 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 44 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 45 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 46 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 47 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 48 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 49 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 50 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 51 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
FIGURE 4 GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, SHARE (%), BY TYPE, 2023
FIGURE 5 GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, SHARE (%), BY METHOD, 2023
FIGURE 6 GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, SHARE (%), BY APPLICATION, 2023
FIGURE 7 GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, SHARE (%), BY REGION, 2023
FIGURE 8 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, SHARE (%), BY REGION, 2023
FIGURE 9 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, SHARE (%), BY REGION, 2023
FIGURE 10 ASIA-PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, SHARE (%), BY REGION, 2023
FIGURE 11 REST OF THE WORLD: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, SHARE (%), BY REGION, 2023
FIGURE 12 GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 13 QIAGEN: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 QIAGEN: SWOT ANALYSIS
FIGURE 15 THERMO FISHER SCIENTIFIC, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 THERMO FISHER SCIENTIFIC, INC.: SWOT ANALYSIS
FIGURE 17 ILLUMINA, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 ILLUMINA, INC.: SWOT ANALYSIS
FIGURE 19 DANAHER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 DANAHER CORPORATION: SWOT ANALYSIS
FIGURE 21 F. HOFFMANN-LA ROCHE LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 F. HOFFMANN-LA ROCHE LTD.: SWOT ANALYSIS
FIGURE 23 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 MERCK KGAA: SWOT ANALYSIS
FIGURE 25 AGILENT TECHNOLOGIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 AGILENT TECHNOLOGIES: SWOT ANALYSIS
FIGURE 27 BIO-RAD LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 BIO-RAD LABORATORIES, INC.: SWOT ANALYSIS
FIGURE 29 TAKARA BIO INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 TAKARA BIO INC.: SWOT ANALYSIS
FIGURE 31 PROMEGA CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 PROMEGA CORPORATION: SWOT ANALYSIS